Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...

Key Takeaways Arrowhead Pharmaceuticals reported a Phase-3 study of its medicine for a rare genetic disorder met all its ...

Shares of Arrowhead Pharmaceuticals on Tuesday climbed in pre-market trading after the company said that it plans to file a new drug application with the U.S. Food and Drug Administration by the end ...

today announced an update for its New Drug Application for Ketamine from the U.S. Food and Drug Administration (the “FDA”) with an assigned a Generic Drug User Fee Amendments of 2022 (“GDUFA ...

Indies Pharma Jamaica Limited has made history as it became the first Jamaican company to get an ANDA (Abbreviated New Drug Application) approved by the United States Food and Drug Administration ...

New Delhi: Indian public health campaigners on Wednesday said they will oppose the patent applications of a promising new but ...

According to UNAIDS, this new HIV drug can offer hope of ending AIDS ... Gilead has several patent applications in India on Lenacapavir. Two of these patent applications, filed in 2020, seek ...

The Company intends to file several related provisional patent applications in the EU with three to four ... Nervous System ("CNS") pathologies will drive investment into new drugs and new drug ...

The Windsor-Essex County Health Unit has confirmed that SafePoint’s application for provincial ... The province’s new strict rules for supervised drug consumption sites means that 10 locations ...

TORONTO, Sept. 04, 2024 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced an update for its ...